Bapcor’s result seemed a touch better than we’d expected, given the trading update indicated sales for the first 6 weeks of the second half were reasonably healthy.

In the exact same manner as our previous note, we’d draw attention to forecast eps growth, which simply looks too high given the macroeconomic weakness they are citing in the retail arm.

Unless there’s a sudden turnaround in the retail sales data, or noticeably lower interest rates (both highlighted below) there’s little to get excited about, in our view. Also, the cash conversion rate, which has been patchy of late, can indicate a company that is “stretching” to hit guidance (a signal of low earnings quality).

So we sit on the sidelines, for now.

From the Q&A call: management did indicate that trends hadn’t broadly changed, in their view, from the 1H, so perhaps that trading update is not extrapolate-able; equally, maybe it means things are getting better and they’ve not yet updated their priors. Difficult to know.

Mgmt also indicated that their market shares have been steady, noting that the press thought (3 months ago) that BAP were losing share, and now (today) seem to be saying they are gaining share, mgmt thought it unchanged, overall.

Important Information: This document has been prepared by Aequitas Investment Partners ABN 92 644 165 266 (“Aequitas”, “our”, “we”), a Corporate Authorised Representative (no. 1284389) of C2 Financial Services, (Australian Financial Services Licensee no. 502171), and is for distribution within Australia to wholesale clients and financial advisers only.

This document is based on information available at the time of publishing, information which we believe is correct and any opinions, conclusions or forecasts are reasonably held or made as at the time of its compilation, but no warranty is made as to its accuracy, reliability or completeness. To the extent permitted by law, neither Aequitas nor any of its affiliates accept liability to any person for loss or damage arising from the use of the information herein.

Please note that past performance is not a reliable indicator of future performance.

General Advice Warning: This document has been prepared without taking into account your objectives, financial situation or needs, and therefore you should consider its appropriateness, having regard to your objectives, financial situation and needs. Before making any decision about whether to acquire a financial product, you should obtain and read the relevant Product Disclosure Statement (PDS) or Investor Directed Portfolio Service Guide (IDPS Guide) and consider talking to a financial adviser.

Taxation warning: Any taxation considerations are general and based on present taxation laws and may be subject to change. Aequitas is not a registered tax (financial) adviser under the Tax Agent Services Act 2009 and investors should seek tax advice from a registered tax agent or a registered tax (financial) adviser if they intend to rely on this information to satisfy the liabilities or obligations or claim entitlements that arise, or could arise, under a taxation law.

Receive our investment insights

Something went wrong. Please check your entries and try again.